DETIL
Live / Registered — Registered (as of 06 Dec 2022)
What this means for you
Registered since 06 Dec 2022. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 88622887
- Registration number
- 6918676
- Mark type
- Stylized text
- Filed
- 19 Sept 2019
- Published for opposition
- 28 Jan 2020
- Registered
- 06 Dec 2022
- Attorney of record
- Gazal Pour-Moezzi
Goods and services
- Class 005 — Pharmaceuticals: Biological and pharmaceutical preparations for the treatment of cancer and immune-related disorders
Owner
- Nurix Therapeutics, Inc., Brisbane, CA, US
- Nurix Therapeutics, Inc., San Francisco, CA, US
- Nurix Therapeutics, Inc., San Francisco, CA, US
Prosecution history
- 24 Nov 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 24 Nov 2025 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 24 Nov 2025 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 24 Nov 2025 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 24 Nov 2025 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 15 Aug 2023 — NOTICE OF UPDATED REGISTRATION CONFIRMATION EMAILED
- 13 Jul 2023 — CORRECTION UNDER SECTION 7 - PROCESSED
- 10 Jul 2023 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 28 Dec 2022 — TEAS SECTION 7 REQUEST RECEIVED
- 06 Dec 2022 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 06 Dec 2022 — REGISTERED-PRINCIPAL REGISTER
- 03 Nov 2022 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 02 Nov 2022 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 28 Sept 2022 — STATEMENT OF USE PROCESSING COMPLETE
- 26 Sept 2022 — USE AMENDMENT FILED